https://investor.ironwoodpharma.com/press-releases/press-release-details/2016/Ironwood-Announces-US-Availability-of-ZURAMPIC-lesinurad-200-mg-Tablets-for-Patients-with-Uncontrolled-Gout/default.aspx
Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.
- October 3, 2016